IOPE SS CONDITIONING FOUNDATION NO.13 SPF22 PA PLUS

Dosage form: lotion
Ingredients: Octinoxate 0.05mL in 1mL, TITANIUM DIOXIDE 0.03mL in 1mL, ZINC OXIDE 0.01mL in 1mL
Labeler: AMOREPACIFIC
NDC Code: 43419-356

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

IOPE
SMALL&SMOOTH
S.S CONDITIONING
FOUNDATION

WARNING LABEL

FOR EXTERNAL USE ONLY. AVOID CONTACT WITH EYES.

DISCONTINUE USE IF SIGNS OF IRRITATION APPEAR,

KEEP OUT OF REACH OF CHILDREN

ACTIVE INGREDIENTS

ETHYLHEXYL METHOXYCINNAMATE 5.0%, TITANIUM DIOXIDE 3.0%, ZINC OXIDE 1.0%

INGREDIENTS

WATER, CYCLOPENTASILOXANE, TITANIUM DIOXIDE, BUTYLENE GLYCOL DICAPRYLATE/DICAPRATE, BUTYLENE GLYCOL, ETHYLHEXYL METHOXYCINNAMATE, DIMETHICONE, POLYMETHYL METHACRYLATE, LAURYL PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE, MICA, DISTEARDIMONIUM HECTORITE, SODIUM CHLORIDE, MINERAL WATER, CAMELLIA SINENSIS LEAF EXTRACT, BETA-GLUCAN, GLYCERIN, HYDROXYPROPYL BISPALMITAMIDE MEA, POLYGLUTAMIC ACID, LAVANDULA STOECHAS EXTRACT, BORON NITRIDE, VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER, SORBITAN ISOSTEARATE, ZINC OXIDE, POLYSILICONE-11, ALUMINUM HYDROXIDE, ACRYLATES/ETHYLHEXYL ACRYLATE/DIMETHICONE METHACRYLATE COPOLYMER, STEARIC ACID, CAPRYLYL LYCOL, TRIETHOXYCAPRYLYLSILANE, ETHYLHEXYLGLYCERIN, DISODIUM EDTA,MANNAN, IRON OXIDES (CI77491, CI77492, CI77499), FRAGRANCE

PRINCIPAL DISPLAY PANEL - 35mL Bottle Carton - NO. 13

IOPE

IOPE

SMALL&SMOOTH

S.S CONDITIONING
FOUNDATION

PRINCIPAL DISPLAY PANEL - 35mL Bottle Carton - NO. 21

IOPE

IOPE

SMALL&SMOOTH

S.S CONDITIONING
FOUNDATION

PRINCIPAL DISPLAY PANEL 35mL Bottle Carton - NO. 23

IOPE

IOPE

SMALL&SMOOTH

S.S CONDITIONING
FOUNDATION

PRINCIPAL DISPLAY PANEL 35mL Bottle Carton - NO. 31

IOPE

IOPE

SMALL&SMOOTH

S.S CONDITIONING
FOUNDATION

IOPE SS   CONDITIONING FOUNDATION NO.13 SPF22 PA PLUS
octinoxate, titanium dioxide, and zinc oxide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43419-356
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate0.05 mL  in 1 mL
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE0.03 mL  in 1 mL
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE0.01 mL  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER 
MICA 
CYCLOMETHICONE 5 
BUTYLENE GLYCOL 
DIMETHICONE 
SODIUM CHLORIDE 
GREEN TEA LEAF 
GLYCERIN 
ALUMINUM HYDROXIDE 
STEARIC ACID 
ETHYLHEXYLGLYCERIN 
EDETATE DISODIUM 
Packaging
#Item CodePackage Description
1NDC:43419-356-0335 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35211/01/2010
IOPE SS   CONDITIONING FOUNDATION NO.21 SPF22 PA PLUS
octinoxate, titanium dioxide, and zinc oxide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43419-357
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate0.05 mL  in 1 mL
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE0.03 mL  in 1 mL
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE0.01 mL  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER 
MICA 
CYCLOMETHICONE 5 
BUTYLENE GLYCOL 
DIMETHICONE 
SODIUM CHLORIDE 
GREEN TEA LEAF 
GLYCERIN 
ALUMINUM HYDROXIDE 
STEARIC ACID 
ETHYLHEXYLGLYCERIN 
EDETATE DISODIUM 
Packaging
#Item CodePackage Description
1NDC:43419-357-0435 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35211/01/2010
IOPE SS   CONDITIONING FOUNDATION NO.23 SPF22 PA PLUS
octinoxate, titanium dioxide, and zinc oxide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43419-358
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate0.05 mL  in 1 mL
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE0.03 mL  in 1 mL
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE0.01 mL  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER 
MICA 
CYCLOMETHICONE 5 
BUTYLENE GLYCOL 
DIMETHICONE 
SODIUM CHLORIDE 
GREEN TEA LEAF 
GLYCERIN 
ALUMINUM HYDROXIDE 
STEARIC ACID 
ETHYLHEXYLGLYCERIN 
EDETATE DISODIUM 
Packaging
#Item CodePackage Description
1NDC:43419-358-0535 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35211/01/2010
IOPE SS   CONDITIONING FOUNDATION NO.31 SPF22 PA PLUS
octinoxate, titanium dioxide, and zinc oxide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43419-359
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate0.05 mL  in 1 mL
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE0.03 mL  in 1 mL
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE0.01 mL  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER 
MICA 
CYCLOMETHICONE 5 
BUTYLENE GLYCOL 
DIMETHICONE 
SODIUM CHLORIDE 
GREEN TEA LEAF 
GLYCERIN 
ALUMINUM HYDROXIDE 
STEARIC ACID 
ETHYLHEXYLGLYCERIN 
EDETATE DISODIUM 
Packaging
#Item CodePackage Description
1NDC:43419-359-0635 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35211/01/2010
Labeler - AMOREPACIFIC (687995683)
Establishment
NameAddressID/FEIOperations
AMOREPACIFIC687995683MANUFACTURE

Revised: 10/2010
 
AMOREPACIFIC

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)